| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 10 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.61M | $82.70M | +7.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Patel Snehal61 | CEO And CFO | Buy | 2,050 | $23.82 | $48,830.80 | +0.2% | -13.7% | -38.2% | |
| Dec 14, 2021 | Patel Snehal61 | CEO And CFO | Buy | 1,840 | $27.17 | $49,992.43 | +0.2% | -21.7% | -49.9% | |
| Dec 14, 2021 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,111 | $26.99 | $29,983.45 | +1.3% | -21.7% | -49.9% | |
| Dec 14, 2021 | McWilliams David | Director | Buy | 200 | $27.56 | $5,512.18 | - | -21.7% | -49.9% | |
| Apr 13, 2021 | Patel Snehal61 | CEO And CFO | Buy | 2,700 | $36.98 | $99,852.75 | +0.2% | +25.6% | -50.8% | |
| Nov 24, 2020 | Hallock Kenneth | - | Buy | 1,000 | $5.39 | $5,386.00 | +0.3% | - | - | |
| Nov 23, 2020 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,000 | $5.10 | $5,100.00 | +1.2% | - | - | |
| Nov 20, 2020 | McWilliams David | - | Buy | 1,500 | $5.40 | $8,100.00 | +0.2% | - | - | |
| Nov 20, 2020 | Hallock Kenneth | - | Buy | 1,000 | $5.37 | $5,370.00 | +0.3% | - | - | |
| Nov 20, 2020 | Rothe Eric | - | Buy | 2,000 | $5.40 | $10,800.00 | +0.6% | - | - |